| Date Filed | Type | Description |
| 05/04/2023 |
4/A
| Walker Marlan D (CEO) has filed a Form 4 on TherapeuticsMD, Inc.|
Txns:
| Sold 692 shares
@ $3.6381, valued at
$2.5k
Exercised 1,010 restricted stock units
@ $0
Exercised 1,734 restricted stock units
@ $0 |
|
| 04/14/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/23/2023 |
4
| Walker Marlan D (CEO) has filed a Form 4 on TherapeuticsMD, Inc.|
Txns:
| Granted 70,000 restricted stock units
@ $0 |
|
| 02/13/2023 |
5
| Form 5 - Annual statement of changes in beneficial ownership of securities: |
| 12/09/2022 |
4
| Walker Marlan D (General Counsel) has filed a Form 4 on TherapeuticsMD, Inc.|
Txns:
| Sold 1,048 shares
@ $4.9475, valued at
$5.2k
Exercised 1,010 restricted stock units
@ $0
Exercised 1,156 restricted stock units
@ $0
Exercised 388 restricted stock units
@ $0 |
|
| 03/31/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/28/2022 |
4
| Walker Marlan D (General Counsel) has filed a Form 4 on TherapeuticsMD, Inc.|
Txns:
| Granted 260,000 restricted stock units
@ $0 |
|
| 03/28/2022 |
4
| Walker Marlan D (General Counsel) has filed a Form 4 on TherapeuticsMD, Inc.|
Txns:
| Granted 260,000 restricted stock units
@ $0 |
|
| 03/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/07/2020 |
3
| Walker Marlan D (General Counsel) has filed a Form 3 on TherapeuticsMD, Inc. |